CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component

Human Pathology

Volumn 39, Issue 1, 2008, Pages 30-36

  Kakar, Sanjay ^a   Deng, Guoren ^a,b   Cun, Lisa ^a   Sahai, Vaibhav ^c   Kim, Young S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adenoma; BRAF; KRAS; Methylation; Villous

Indexed keywords

ARTICLE; BRAF GENE; COLORECTAL ADENOMA; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; GENE; GENE MUTATION; HUMAN; KRAS GENE; MAJOR CLINICAL STUDY; PHENOTYPE; TUBULOVILLOUS ADENOMA; TUMOR VOLUME; VILLOUS ADENOMA;

ADENOMA, VILLOUS; COLORECTAL NEOPLASMS; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; HUMANS; MICROSATELLITE INSTABILITY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS;

EID: 36749036049     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.06.002     Document Type: Article

References (33)

1. Toyota M., Ohe-Toyota M., Ahuja N., and Issa J.P. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci U S A 97 (2000) 710-715
2. Hawkins N., Norrie M., Cheong K., et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 122 (2002) 1376-1387
3. Samowitz W.S., Albertsen H., Herrick J., et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129 (2005) 837-845
4. Park S.J., Rashid A., Lee J.H., Kim S.G., Hamilton S.R., and Wu T.T. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 162 (2003) 815-822
5. Chan T.L., Zhao W., Leung S.Y., Yuen S.T., and Cancer Genome Project. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 63 (2003) 4878-4881
6. Kambara T., Simms L.A., Whitehall V.L., et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53 (2004) 1137-1144
7. Yang S., Farraye F.A., Mack C., Posnik O., and O'Brien M.J. BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 28 (2004) 1452-1459
8. Dong S.M., Lee E.J., Jeon E.S., Park C.K., and Kim K.M. Progressive methylation during the serrated neoplasia pathway of the colorectum. Mod Pathol 18 (2005) 170-178
9. O'Brien M.J., Yang S., Mack C., et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30 (2006) 1491-1501
10. Rashid A., Shen L., Morris J.S., Issa J.P., and Hamilton S.R. CpG island methylation in colorectal adenomas. Am J Pathol 159 (2001) 1129-1135
11. Petko Z., Ghiassi M., Shuber A., et al. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res 11 (2005) 1203-1209
12. Kim H.C., Roh S.A., Ga I.H., Kim J.S., Yu C.S., and Kim J.C. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer. J Gastroenterol Hepatol 20 (2005) 1920-1926
13. Kim Y.H., Petko Z., Dzieciatkowski S., et al. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer 45 (2006) 781-789
14. Hamilton S.R., Vogelstein B., Kudo S., et al. Carcinoma of colon and rectum. In: Hamilton S.R., and Aaltonen L.A. (Eds). Tumors of the digestive system, pathology and genetics (2000), IARC press, Lyon, France 104-119
15. Atkin W.S., Morson B.C., and Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326 (1992) 658-662
16. Martinez M.E., Sampliner R., Marshall J.R., Bhattacharyya A.K., Reid M.E., and Alberts D.S. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 120 (2001) 1077-1083
17. Loeve F., van Ballegooijen M., Snel P., and Habbema J.D. Colorectal cancer risk after colonoscopic polypectomy: a population-based study and literature search. Eur J Cancer 41 (2005) 416-422
18. Winawer S.J., Zauber A.G., Fletcher R.H., et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 130 (2006) 1872-1885
19. Kim D.H., Kim J.W., Cho J.H., et al. Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum. Int J Oncol 27 (2005) 957-964
20. Tanaka H., Deng G., Matsuzaki K., et al. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer. Int J Cancer 118 (2006) 2765-2771
21. Noshirwani K.C., van Stolk R.U., Rybicki L.A., and Beck G.J. Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc 51 (2000) 433-437
22. Pegg A.E., Dolan M.E., and Moschel R.C. Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol 51 (1995) 167-223
23. Esteller M., Toyota M., Sanchez-Cespedes M., et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 60 (2000) 2368-2371
24. Esteller M., Risques R.A., Toyota M., et al. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 61 (2001) 4689-4692
25. Whitehall V.L., Walsh M.D., Young J., Leggett B.A., and Jass J.R. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 61 (2001) 827-830
26. Kakar S., Burgart L.J., Thibodeau S.N., et al. Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age. Cancer 97 (2003) 1421-1427
27. Fox E.J., Leahy D.T., Geraghty R., et al. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer. J Mol Diagn 8 (2006) 68-75
28. Park H.W., Kang H.C., Kim I.J., et al. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers. Int J Cancer 120 (2007) 7-12
29. Khokhlatchev A., Rabizadeh S., Xavier R., et al. Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol 12 (2002) 253-265
30. Akino K., Toyota M., Suzuki H., et al. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology 129 (2005) 156-169
31. Hesson L.B., Wilson R., Morton D., et al. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations. Oncogene 24 (2005) 3987-3994
32. Maltzman T., Knoll K., Martinez M.E., et al. Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. Gastroenterology 121 (2001) 302-309
33. Barry E.L., Baron J.A., Grau M.V., Wallace K., and Haile R.W. K-ras mutations in incident sporadic colorectal adenomas. Cancer 106 (2006) 1036-1040